DRAP and Provincial Regulators Unite to Boost Market Surveillance

Meanwhile, the Drug Regulatory Authority of Pakistan (DRAP), in collaboration with provincial and state drug control administrations, has concluded a three-day workshop to strengthen market surveillance, regulatory coordination, and quality assurance of medical products nationwide.

BusinessNews Info Wire3 min read
DRAP Introduces Barcodes and Unique Serial Numbers for Medicines

Meanwhile, the Drug Regulatory Authority of Pakistan (DRAP), in collaboration with provincial and state drug control administrations, has concluded a three-day workshop to strengthen market surveillance, regulatory coordination, and quality assurance of medical products nationwide.

Article outline

  1. What happened
  2. Why it matters
  3. The key numbers
  4. The bottom line

Key points

  • Morphine Injections Expire at Major Govt Hospital in Karachi.
  • The workshop additionally highlighted the importance of coordinated efforts to identify and prevent the circulation of substandard and falsified medical products.
  • Emphasizing the need for a stronger national regulatory framework, participants reaffirmed their commitment to improving interprovincial cooperation, strengthening market control mechanisms and enhancing the effectiveness of regulatory operations.
  • Obtain the latest news and stories wherever you prefer.

In practice, the workshop focused on risk-based sampling, market surveillance, the Market Control Dashboard and Electronic Quality Management Systems (eQMS), bringing together regulatory authorities from throughout Pakistan to share experiences and enhance their technical capacity.

With technical backing from the World Health Organization (WHO), the initiative seeks to strengthen coordination among federal, provincial and state regulatory authorities and promote a unified approach to regulating medical products. Body Cameras Ordered for Inspection of Pharmacy Institutes.

Participants discussed strategies to improve risk-based sampling, enhance market monitoring and strengthen the employ of digital systems to backing regulatory decisions and ensure more effective oversight of medical products.

In practice, the workshop additionally highlighted the importance of coordinated efforts to identify and prevent the circulation of substandard and falsified medical products. It pose significant risks to patient safety and public health.

Meanwhile, the adoption of electronic quality management systems and improved market surveillance tools is projected to backing more efficient regulatory processes, strengthen information-sharing among authorities and facilitate timely responses to emerging product safety reservations. Morphine Injections Expire at Major Govt Hospital in Karachi.

Notably, the initiative forms part of broader efforts to develop a stronger, more responsive and resilient National Regulatory System capable of ensuring that medical products available in Pakistan meet established standards of safety, efficacy and quality.

DRAP and its provincial and state counterparts reiterated their commitment to working collectively to protect patients, improve regulatory performance and promote access to safe, effective and quality-assured medical products throughout the country. Stay Connected with ProPakistani. Obtain the latest news and stories wherever you prefer. Follow on Google Discover. Follow on Google News Join WhatsApp. See more ProPakistani stories in Google Search and Top Stories.

In short, DRAP and Provincial Regulators Unite to Boost Market Surveillance is the central thread here, and readers can expect follow-up reporting as the picture becomes clearer.

Leave a Reply

Your email address will not be published. Required fields are marked *